Timothy E. Schlub

8.7k citations

89 papers · 4.5k indexed · 2 hit papers · h-index 28

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in

Virology 23
- HIV Research and Treatment 22
Infectious Diseases 28
- HIV/AIDS Research and Interventions 13
- HIV/AIDS drug development and treatment 10
- SARS-CoV-2 and COVID-19 Research 8

Co-authors: Miles P. Davenport Deborah Cromer Arnold Reynaldi Stephen J. Kent David S. Khoury James A. Triccas Kanta Subbarao Adam K. Wheatley
Journals: Journal of Virology (5 papers)Nature Communications (4 papers)The Journal of Infectious Diseases (4 papers)AIDS (4 papers)Psycho-Oncology (3 papers)
Partner nations: Australia United States Canada

In The Last Decade

Timothy E. Schlub

88 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection 2023 · 72 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Emerging infectious diseases
2021 Nature Medicine

Peers

Countries citing papers authored by Timothy E. Schlub

Since Specialization

Citations

This map shows the geographic impact of Timothy E. Schlub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Schlub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Schlub more than expected).

Fields of papers citing papers by Timothy E. Schlub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy E. Schlub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Schlub. The network helps show where Timothy E. Schlub may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Timothy E. Schlub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy E. Schlub Line = papers co-authored together Timothy E. Schlub links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Saffron therapy for the ongoing treatment of age-related macular degeneration BMJ Open Ophthalmology ·Geoffrey Broadhead, John Grigg, Peter McCluskey, Thomas Hong, Timothy E. Schlub, Jackie Douglas, Andrew Chang	2024	3
2	Predicting vaccine effectiveness for mpox Nature Communications ·Hannah Mariko Thorner, Shanchita R. Khan, Timothy E. Schlub, Dhanush R. Giriyan, Mohana Kunasekaran, Andrew E. Grulich, C. Raina MacIntyre, Miles P. Davenport, David S. Khoury	2024	29
3	Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis The Lancet Microbe ·Katie M. Norgard, Shanchita R. Khan, Eva Stadler, Timothy E. Schlub, Deborah Cromer, Mark N. Polizzotto, Stephen J. Kent, Tari Turner, Miles P. Davenport, David S. Khoury	2024	9
4	Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis medRxiv ·Katie M. Norgard, Shanchita R. Khan, Eva Stadler, Timothy E. Schlub, Deborah Cromer, Mark N. Polizzotto, Stephen J. Kent, Tari Turner, Miles P. Davenport, David S. Khoury	2023	1
5	Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1 Familial Cancer ·勝輝葛西, Jane Fleming, K. Moore, Ashley Crook, 孙金海, Sarah Choi, Timothy E. Schlub, Michael Field, Lotte Y. Astorp, Jeff Thompson, Yemima Berman	2023	1
6	Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 Frontiers in Immunology ·H.J. Zondag, Timothy E. Schlub, Elena Piazuelo Ortega, Thomas A. Rasmussen, Ajantha Rhodes, Rebecca Hoh, Frederick Hecht, Steven G. Deeks, Sharon R. Lewin, Sarah Palmer	2023	7
7	Monoclonal antibody levels and protection from COVID-19 Nature Communications ·Eva Stadler, Apollinaire Edou, Timothy E. Schlub, Shanchita R. Khan, Khai Li Chai, Zoe McQuilten, Erica M. Wood, Mark N. Polizzotto, Stephen J. Kent, Deborah Cromer, Miles P. Davenport, David S. Khoury	2023	26
8	Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals Journal of Virology ·W McCune, Jennifer M. Zerbato, Anchalee Avihingsanon, H.J. Zondag, Timothy E. Schlub, Ajantha Rhodes, Jennifer Audsley, Kasha P. Singh, Wei Zhao, Sharon R. Lewin, Sarah Palmer	2022	5
9	Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting European Journal of Human Genetics ·Megan Best, Phyllis Butow, Namoi Roht-Arriaza, Chris Jacobs, Nicci Bartley, Reissa Kayana, Christine E. Napier, Mandy L. Ballinger, David M. Thomas, Barbara B. Biesecker, Kathy Tucker, Ilona Juraskova, Bettina Meiser, Timothy E. Schlub, Ainsley J. Newson	2022	5
10	Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results Psycho-Oncology ·Megan Best, Christine E. Napier, Timothy E. Schlub, Nicci Bartley, Barbara B. Biesecker, Mandy L. Ballinger, Phyllis Butow	2022	4
11	Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over Time The Journal of Infectious Diseases ·Bethany A. Horsburgh, Bonnie Hiener, H.J. Zondag, Eunok Lee, 傅丽君, John‐Sebastian Eden, Susanne von Stockenström, Julia Christine Lengen, Jeffrey M. Milush, Rebecca Hoh, Rémi Fromentin, Nicolas Chomont, Frederick Hecht, Timothy E. Schlub, Steven G. Deeks, Sarah Palmer	2021	12
12	HIV-1 Genomes Are Enriched in Memory CD4 ⁺ T-Cells with Short Half-Lives mBio ·渡辺拓己, Zhang Bo, H.J. Zondag, Bethany A. Horsburgh, Bonnie Hiener, W McCune, Timothy E. Schlub, Mark Fitch, Rebecca Hoh, Frederick Hecht, Jeffrey N. Martin, Steven G. Deeks, Marc K. Hellerstein, Joseph M. McCune, Peter W. Hunt, Sarah Palmer	2021	17
13	Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling American Journal of Medical Genetics Part A ·Bettina Meiser, Phyllis Butow, Reissa Kayana, Christine E. Napier, Timothy E. Schlub, Nicci Bartley, Ilona Juraskova, Mandy L. Ballinger, David M. Thomas, Kathy Tucker, David Goldstein, Barbara B. Biesecker, Megan Best, (unknown)	2021	1
14	Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection Nature Medicine ·David S. Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E. Schlub, Adam K. Wheatley, Jennifer A. Juno, Kanta Subbarao, Stephen J. Kent, James A. Triccas, Miles P. Davenport Hit paper breakdown →	2021	2105
15	Cancer patient knowledge about and behavioral intentions after germline genome sequencing Patient Education and Counseling ·Christine E. Napier, Reissa Kayana, Phyllis Butow, Timothy E. Schlub, Megan Best, Nicci Bartley, Ilona Juraskova, Bettina Meiser, Kathy Tucker, Barbara B. Biesecker, David M. Thomas, Mandy L. Ballinger	2021	3
16	High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies AIDS ·Bethany A. Horsburgh, Eunok Lee, Bonnie Hiener, John‐Sebastian Eden, Timothy E. Schlub, Susanne von Stockenström, Julia Christine Lengen, Jeffrey M. Milush, Teri Liegler, Elizabeth Sinclair, Rebecca Hoh, Eli Boritz, Daniel C. Douek, Rémi Fromentin, Nicolas Chomont, Steven G. Deeks, Frederick Hecht, Sarah Palmer	2020	30
17	Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood ACS Nano ·Yi Ju, Hannah G. Kelly, Laura F. Dagley, Arnold Reynaldi, Timothy E. Schlub, Sukhdeep K. Spall, Craig A. Bell, Jiwei Cui, Andrew J. Mitchell, Zhixing Lin, Adam K. Wheatley, Kristofer J. Thurecht, Miles P. Davenport, Andrew I. Webb, Frank Caruso, Stephen J. Kent	2020	91
18	Advanced cancer patient preferences for receiving molecular profiling results Psycho-Oncology ·Megan Best, Phyllis Butow, Chris Jacobs, Ilona Juraskova, Namoi Roht-Arriaza, Bettina Meiser, David Goldstein, Mandy L. Ballinger, Nicci Bartley, Christine E. Napier, Reissa Kayana, David M. Thomas, Kathy Tucker, Timothy E. Schlub, Ainsley J. Newson, (unknown)	2020	7
19	Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants Malaria Journal ·Arnold Reynaldi, Arlene E. Dent, Timothy E. Schlub, Sidney Ogolla, Rosemary Rochford, Miles P. Davenport	2019	10
20	Impact ofPlasmodium falciparumCoinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children The Journal of Infectious Diseases ·Arnold Reynaldi, Timothy E. Schlub, Kiprotich Chelimo, Peter Odada Sumba, Erwan Piriou, Sidney Ogolla, Ann M. Moormann, Rosemary Rochford, Miles P. Davenport	2015	27

About Timothy E. Schlub

Timothy E. Schlub is a scholar working on Virology, Infectious Diseases, Ophthalmology, Immunology and Genetics, having authored 89 papers that have together received 4.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (15 papers), BRCA gene mutations in cancer (14 papers), HIV/AIDS Research and Interventions (13 papers), HIV/AIDS drug development and treatment (10 papers), Cancer Genomics and Diagnostics (9 papers), T-cell and B-cell Immunology (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). The work is most often cited by research in Virology (849 citations), Infectious Diseases (2.8k citations), Modeling and Simulation (268 citations), Health (414 citations) and Immunology (798 citations). Timothy E. Schlub has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Miles P. Davenport, Deborah Cromer, Arnold Reynaldi, Stephen J. Kent, David S. Khoury, James A. Triccas, Kanta Subbarao, Adam K. Wheatley, Jennifer A. Juno and Edward C. Holmes. Their work appears in journals such as Journal of Virology, Nature Communications, The Journal of Infectious Diseases, AIDS and Psycho-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact